Clinical Trials Browser

Phase 2/3 × Completed × Sorafenib × Clear all

NCT02474290 2019-08-26

Sorafenib for Prophylaxis of Leukemia Relapse in Allo-HSCT Recipients With FLT3-ITD Positive AML

Phase 2/3 Completed

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT01932385 2018-02-14

Sorafenib in Liver Function Impaired Advanced Hepatocellular Carcinoma

Phase 2/3 Completed

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT01901692 2017-09-18

START

Phase 2/3 Completed

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms